The Dark Side of Our Genealogy Craze
By Honor Sachs,
The Washington Post
| 12. 13. 2019
Understanding our roots may foster empathy — or division.
This holiday season, millions of Americans will receive gifts allowing them to explore their genealogy and ancestry. People will give loved ones DNA testing kits or subscriptions to ancestry websites, allowing them to map out their global origins and trace their ancestors’ journeys to America from around the world. This advent of popular genealogy illuminates our diverse origins and highlights how immigration histories are critical parts of our personal stories and national narratives. But the rise of genealogy may also, paradoxically, exacerbate the virulently anti-immigration fervor propelling President Trump’s policies and increase racial inequality. How do we know this? Because it happened before.
The last time Americans experienced a genealogy revival on a scale similar to today was during the 1970s when Alex Haley published “Roots: The Saga of an American Family.” Haley’s story followed the life of the mostly fictional Kunta Kinte from his capture in 18th-century Gambia to his life as a slave in the United States, and traces the lives of his descendants over two centuries and seven generations, culminating with a family connection to Haley himself...
Related Articles
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...